door admin | feb 5, 2026 | news
*Seminar Alert!* Registration is now open for our February Seminar! Topic: “SERENITY: developing an evidence-based decision support tool to support shared decisions about continuing or discontinuing antithrombotic medication for people with cancer towards the...
door admin | jan 12, 2026 | news
We are developing a decision support tool We are developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Results of a European Delphi...
door admin | dec 12, 2025 | news
Serenity joins the Quality of Life and Patient-Centred Care (QoL-PCC) cluster The cluster represents a key opportunity to advance oncology care. One of the main goals is to develop a unified vision around these concepts while establishing core axes related to Patient...
door admin | okt 12, 2025 | news
WP4: Delphi Process Through this Delphi study, the following aspects will be defined:Β characterisation of candidate patients for discussion about ATT deprescribing healthcare team roles in ATT decision-making specific information and communication requirements for...
door admin | sep 12, 2025 | news
Who am I to stop taking my medication? Who am I to stop taking my medication – π’ π±π’π΅πͺπ¦π―π΅ π’π΄π¬π¦π₯ πͺπ― π°πΆπ³ π³π¦π€π¦π―π΅ π΄π΅πΆπ₯πΊ.When we as professionals want to stop medication, we often focus on the clinical reasoning: Risk of bleeding. Limited benefit. A burden.All true β...
door admin | sep 1, 2025 | news
New publication in British Journal of Haematology Retrospective cohort study of adults in Wales diagnosed with poor prognosis cancer between 2013 and 2021, following up patients from cancer diagnosis until death, end of follow-up or study end (31 December 2021)....
